About
Team
Management
Board
Investors
Lead Candidate
Investors
Investor Overview
Press Releases
Events and Presentations
Corporate Governance
Governance Documents
Board of Directors
Board Committees
Stock Information
Interactive Chart
Investment Calculator
Historical Stock Price
SEC Filings
Insider Transactions
Investor Resources
Investor Alerts
Information Request
Analyst Coverage
News
Publications
Careers
Contact
About
Team
Management
Board
Investors
Lead Candidate
Investors
Investor Overview
Press Releases
Events and Presentations
Corporate Governance
Governance Documents
Board of Directors
Board Committees
Stock Information
Interactive Chart
Investment Calculator
Historical Stock Price
SEC Filings
Insider Transactions
Investor Resources
Investor Alerts
Information Request
Analyst Coverage
News
Publications
Careers
Contact
Press Releases
Investor Alerts
Year
All Years
2019
Keywords
Go
Advanced Search
Search
Search Headlines Only
From
To
Asset Types
Photos
Video
Audio
Documents
Events
Standard
Sep 17, 2019
Satsuma Pharmaceuticals, Inc. Announces Closing of Initial Public Offering
Sep 12, 2019
Satsuma Pharmaceuticals, Inc. Announces Pricing of Initial Public Offering of Common Stock
Sep 3, 2019
Satsuma Pharmaceuticals Announces Poster Presentations at the International Headache Congress
Sep 3, 2019
Satsuma Pharmaceuticals, Inc. Announces Proposed Initial Public Offering of Common Stock
Aug 22, 2019
Satsuma Pharmaceuticals Announces First Patient Dosed in EMERGE™, a Phase 3 Efficacy Trial of STS101 for the Acute Treatment of Migraine
Show
5
10
25
50
100
per page
«
1
2
3
»
MENU
About
Team
Management
Board
Investors
Lead Candidate
Investors
Investor Overview
Press Releases
Events and Presentations
Corporate Governance
Governance Documents
Board of Directors
Board Committees
Stock Information
Interactive Chart
Investment Calculator
Historical Stock Price
SEC Filings
Insider Transactions
Investor Resources
Investor Alerts
Information Request
Analyst Coverage
News
Publications
Careers
Contact
